Market cap
$263 Mln
Revenue (TTM)
$168 Mln
P/E Ratio
--
P/B Ratio
6.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 58.04 | 47.62 | 2.32 | 3.22 | 7.33 |
| EBIT | -104.63 | -84.60 | -154.13 | -314.50 | 5.77 |
| Net Profit | 153.07 | 153.83 | 59.91 | -225.12 | 13.54 |
| EPS | 152.95 | 153.44 | 59.92 | -227.01 | 13.67 |
| Book Value | -- | -- | -52.51 | -27.52 | -30.51 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -33.92 | -89.95 | -52.26 | -44.67 | -43.76 |
| Net Margin
| -- | -164.10 | -8.70 | -- | -- |
| Return on equity
| -47.65 | -55.42 | -29.64 | -86.95 | -49.85 |
| Return on Capital
| -30.54 | -42.12 | -- | -47.25 | -39.38 |
| Return on Assets
| -18.59 | -29.53 | -3.07 | -28.78 | -23.91 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.92 | 0.32 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
-47.25
|
-39.38
|
-4.98
|
-54.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-29.64
Higher than Peers by 10.76
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-29.64
|
-86.95
|
-49.85
|
-6.15
|
-62.90
|
|
Peer Median
|
-40.40
|
--
|
--
|
--
|
--
|
ROA
-3.07
Higher than Peers by 27.91
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-3.07
|
-28.78
|
-23.91
|
-3.08
|
-38.42
|
|
Peer Median
|
-30.98
|
--
|
--
|
--
|
--
|
EBIT Margin
-52.26
Higher than Peers by 31.36
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-52.26
|
-44.67
|
-43.76
|
-13.34
|
-79.91
|
|
Peer Median
|
-83.62
|
--
|
--
|
--
|
--
|
Net Margin
-8.70
Higher than Peers by 83.97
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-8.70
|
-49.91
|
-45.14
|
-15.84
|
-78.14
|
|
Peer Median
|
-92.67
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
2.32
Lower than Peers by 51.63
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
2.32
|
0.01
|
1.59
|
-0.62
|
1.01
|
|
Peer Median
|
53.95
|
--
|
--
|
--
|
--
|
EBIT Growth
-154.13
Lower than Peers by 153.33
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-154.13
|
-2.89
|
-750.90
|
93.72
|
40.13
|
|
Peer Median
|
-0.80
|
--
|
--
|
--
|
--
|
Net Profit Growth
59.91
Higher than Peers by 67.21
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
59.91
|
-11.43
|
-639.30
|
92.45
|
37.11
|
|
Peer Median
|
-7.30
|
--
|
--
|
--
|
--
|
EPS Growth
59.92
Higher than Peers by 45.27
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
59.92
|
-0.10
|
-6.31
|
0.93
|
0.37
|
|
Peer Median
|
14.65
|
--
|
--
|
--
|
--
|
Book Value Growth
-8.70
Higher than Peers by 1.48
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-8.70
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
1.92
|
0.32
|
0.22
|
0.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.12
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
0.12
|
0.09
|
0.04
|
0.02
|
0.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.96
Lower than Peers by 2.85
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
2.96
|
5.10
|
3.92
|
4.48
|
4.57
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
2.96
Lower than Peers by 2.74
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
2.96
|
4.92
|
3.92
|
4.46
|
4.54
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
-5.19
Lower than Peers by 3.10
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-5.19
|
-7.85
|
-58.21
|
-5.33
|
-461.67
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
85.98
Higher than Peers by 66.84
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
85.98
|
8.95
|
2.90
|
18.13
|
37.00
|
|
Peer Median
|
19.14
|
--
|
--
|
--
|
--
|
Asset Turnover
0.35
Higher than Peers by 0.29
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
0.35
|
0.58
|
0.53
|
0.19
|
0.49
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
21.60
|
18.07
|
212.63
|
80.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
33.45
|
18.13
|
59.35
|
144.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
41.45
|
170.11
|
251.93
|
504.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
13.61
|
-133.91
|
20.05
|
-280.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
-1.36
|
-3.04
|
-65.77
|
-3.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
6.08
Higher than Peers by 0.90
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
6.08
|
1.83
|
1.75
|
3.90
|
2.90
|
|
Peer Median
|
5.18
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-1.54
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
-1.54
|
-0.31
|
-0.69
|
198.28
|
-2.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
263
Higher than Peers by 117
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
MacroGenics (MGNX)
|
263
|
--
|
--
|
--
|
--
|
|
Peer Median
|
146
|
--
|
--
|
--
|
--
|